3522 results for «2011»
3522 results
Start treating refractory angina patients with Reducer therapy - Practical aspects
17 May 2022 – From EuroPCR 2022
Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...

DCB and the possibility of a clean vessel
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...

What's next in DES technology? Innovative DES platforms combining DES with DCB
19 May 2022 – From EUROPCR 2022
Via a series of case presentations, learn more about the dual drug delivery from DES and DCB platform to treat diabetes mellitus patients. Understand its efficiency in a complex setting and see how a no-polymer DES and DCB platform can fill the gaps of the unmet...

2022: a tipping point in the treatment of mitral regurgitation patients
17 May 2022 – From EuroPCR 2022
With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.

EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.

How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to become aware of the importance of relying on less contrast injections to guide PCI in complex patients, to learn what skills are required and tools available to perform ultra-low contrast coronary interventions, and to share and discuss such a recorded intervention from...

Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.

Lifetime management of patients with severe aortic stenosis - Securing long-term benefits
17 May 2022 – From EuroPCR 2022
Watching this EuroPCR 2022 session on lifetime management of patients with aortic stenosis will help you understand the importance of the heart team in patient specific treatment and how procedural refinement may optimise long-term outcomes.

Stent failure: how to treat, how to prevent
18 May 2022 – From EuroPCR 2022
With 2 expert interviews, a stent failure case example, and a recorded best practice case to prevent stent failure in this EuroPCR 2022 session, understand why unraveling the mechanism of stent failure is essential for optimal treatment, receive tips and tricks to effectively treat stent failure,...

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary artery disease! Abbreviated DAPT after complex PCI in high bleeding risk patients, comparing conventional and haemostatic dressings in radial access, angio-based QFR virtual PCI vs. conventional angio-guided PCI, CRUZ-HBR, CT-guided invasive coronary angiography in patients with...

Robotic-assisted intervention: latest clinical insights and applications for complex PCI
18 May 2022 – From EuroPCR 2022
How does robotic assistance work in practice in the cathlab? This is the main question this EuroPCR 2022 session aims to answer. Watch it if you wish to understand the functions and capabilities of the Corpath GRX system, learn from a recorded case about best procedural practices and workflow...

EuroPCR 2022 Early experience and registry results in TAVI: Optimize PRO, FORWARD PRO, Neo-Align, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in TAVI! ACURATE neo2 post-procedural hemodynamic outcomes, first real-world results of the JenaValve TAVI system, Optimize PRO study, a next-generation aortic transcatheter heart valve, commissural alignment, and three-year outcomes following TAVI with a self-expanding valve with pericardial wrap.

Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release
18 May 2022 – From EuroPCR 2022
Thanks to this EuroPCR 2022 session, discuss how sustained limus release technology can broaden DEB indications, learn about the decision-making process on the use of DEB adjacent to DES in complex PCI, and review DEB specific implantation techniques to achieve optimal outcomes for the patient.

The right valve choice for TAVI patient longevity and durability
18 May 2022 – From EuroPCR 2022
Watch this session to learn about the impact of age and life expectancy on decision-making for TAVI, to become aware of the durability data of the current TAVI platform, and to revise contemporary implantation techniques and procedural goals for future TAVI-in-TAVI.

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and...

The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...

Mitral replacement: expanding patient options, even mitral annular calcification!
18 May 2022 – From EUROPCR 2022
The objectives of this session from EuroPCR 2022 are to provide the best pathway for mitral regurgitation management, to learn about early commercial TMVR experience and to discover treatment options for mitral annular calcification patients.

EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...

Left main and complex bifurcation PCI in high bleeding risk patients
View the life challenging case of a 90-year-old male patient with a very active lifestyle but hypertension, dyslipidemia, ex-smoker, who presented with left main bifurcation lesion, and appreciate the value of transradial approach for left main and complex bifurcation PCI, acknowledge Ultimaster DES results in bifurcations and high...
